2008-03-25

New business opportunities for Distrupol after successful Medtec UK 2008

The Medtec UK 2008 (13-14 February in Birmingham) has been a major success for polymer distributor and service provider Distrupol. This was Distrupol’s first time exhibiting at the event where it generated over 60 new sales leads, three of which have already resulted in tool trials of polymers supplied by the company. Distrupol believes the excellent response at the show was largely down to the availability of its own Development Engineers, and those of its material suppliers, to discuss product development opportunities and polymer solutions at the stand.

“Medtec 2008 has been one of our most successful shows in recent years,” comments John Brenchley, Marketing and Medical Product Manager, Distrupol. “Projects for the medical sector normally have long lead times, but the availability of our own development experts at Medtec UK meant we could immediately shorten that period in providing direct feedback to visiting companies and generate valuable new business leads immediately. Indeed, visitors to the Distrupol stand were delighted to be able to get on-the-spot responses to their material and design queries.”

Distrupol shared its stand at Medtec with several of its suppliers, including VTC Elastoteknik, with its range of SEBS materials for use in medical tubing and mouldings and DuPont Engineering Polymers, with information on its range of high-performance polymer grades for healthcare components. Ineos Polyolefins used the show as an opportunity to discuss its new Eltex® MED range of medical-grade LDPE materials, which Distrupol is delighted to have recently added to its portfolio. There was also strong interest among visitors - mainly designers and engineers from UK and European medical component manufacturers - for Zylar® Clear acrylic copolymers from Ineos Nova. This polymer is an ideal candidate for replacing polycarbonate in syringes and drug delivery systems.

Distrupol has consistently developed and grown its medical expertise over the last five years while building up a comprehensive portfolio of medical-grade polymers from a number of raw material suppliers. All medical polymers offered by Distrupol are compliant with the requirements of United States Pharmacopeia (USP), or International Standards Organisations (ISO) cycotoxicity or United States Food and Drug Administration (FDA) approvals or Drug Master File (DMF) listings. To further assist in selecting the best material solution for particular medical applications, Distrupol’s medical comparator card is available online at www.distrupol.com.

Distrupol will also participate in the Medical Design Debate during the PDM show at the Telford International Centre. The Debate is scheduled for Wednesday 16th April, room 1, from 14:30 to 15:30, and will focus on some of the key design and manufacturing issues in the medical industry. Distrupol will again be at full strength highlighting it’s medical range of polymers.at MEDTEC Ireland, which is held on 24 and 25 September 2008 at the Radisson SAS Hotel in Galway.

Information about the company: Distrupol Nordic AB